title: Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities.
authors: Department of Hematology, Hospital del Mar-IMIM , Barcelona , Spain.
authors: Blanca
authors: B
authors: Sanchez-Gonzalez
authors: Agueda
authors: A
authors: Ancochea
authors: Francesc
authors: F
authors: Garcia-Pallarols
authors: Carmen
authors: C
authors: Jimenez
authors: Carme
authors: C
authors: Pedro
authors: Carles
authors: C
authors: Besses
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy*; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000276:immunology*; D013926:Thrombopoietin / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D014859:Warfarin; D013926:Thrombopoietin